HK135793A - Liposomes from synthetic lipids - Google Patents

Liposomes from synthetic lipids

Info

Publication number
HK135793A
HK135793A HK1357/93A HK135793A HK135793A HK 135793 A HK135793 A HK 135793A HK 1357/93 A HK1357/93 A HK 1357/93A HK 135793 A HK135793 A HK 135793A HK 135793 A HK135793 A HK 135793A
Authority
HK
Hong Kong
Prior art keywords
liposomes
synthetic lipids
synthetic
substantially pure
relates
Prior art date
Application number
HK1357/93A
Other languages
English (en)
Inventor
Lajos Dr Tarcsay
Hansjoerg Prof Dr Eibl
Peter Dr Fankhauser
Anita Dr Peil
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of HK135793A publication Critical patent/HK135793A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK1357/93A 1984-10-16 1993-12-09 Liposomes from synthetic lipids HK135793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH495184 1984-10-16

Publications (1)

Publication Number Publication Date
HK135793A true HK135793A (en) 1993-12-17

Family

ID=4285361

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1357/93A HK135793A (en) 1984-10-16 1993-12-09 Liposomes from synthetic lipids

Country Status (21)

Country Link
US (1) US4971802A (xx)
EP (1) EP0178624B1 (xx)
JP (2) JPH0618773B2 (xx)
KR (1) KR890000908B1 (xx)
AT (1) ATE58474T1 (xx)
AU (1) AU590221B2 (xx)
CA (1) CA1260393A (xx)
DD (1) DD239117A5 (xx)
DE (1) DE3580648D1 (xx)
DK (1) DK165220C (xx)
ES (1) ES8700934A1 (xx)
FI (1) FI86371C (xx)
GR (1) GR852492B (xx)
HK (1) HK135793A (xx)
HU (1) HU198128B (xx)
IE (1) IE58143B1 (xx)
IL (1) IL76700A (xx)
NO (1) NO171443C (xx)
PH (1) PH22978A (xx)
PT (1) PT81298B (xx)
ZA (1) ZA857888B (xx)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562421B1 (fr) * 1984-04-09 1989-02-17 Sandoz Sa Perfectionnements a la therapie par l'interleukine
US5243062A (en) * 1984-10-12 1993-09-07 Ciba-Geigy Corporation Substituted propane-phosphonous acid compounds
JPS61172833A (ja) * 1985-07-17 1986-08-04 Nakanishi Michio 消炎鎮痛性医薬組成物
US5133973A (en) * 1986-08-07 1992-07-28 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg Pharmaceutical preparations
PT85537B (pt) * 1986-08-18 1990-06-29 Univ Texas Processo para a preparacao de um sistema de administracao farmaceutica contendo peptidos apresentando quimiotaxia
JPH0761940B2 (ja) * 1986-11-17 1995-07-05 株式会社資生堂 外皮用リポソ−ム製剤
EP0274219A3 (en) * 1986-12-04 1988-08-03 Takeda Chemical Industries, Ltd. Interleukin-2-containing liposome composition and method for the production thereof
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
FI874742A (fi) * 1987-10-28 1989-04-29 K & V Licencing Oy Foerfarande foer framstaellning av liposomer.
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
DE3806852A1 (de) * 1988-03-03 1989-09-14 Knoll Ag Neue (alpha)-aminodicarbonsaeure-derivate, ihre herstellung und verwendung
EP0440742B1 (en) * 1988-10-27 1997-01-15 The Regents Of The University Of Minnesota Liposome immunoadjuvants containing il-2
US5466468A (en) * 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
ATE108328T1 (de) * 1990-04-03 1994-07-15 Ciba Geigy Ag Parenteral applizierbare liposomenformulierung aus synthetischen lipiden.
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
EP0467838A3 (en) * 1990-07-17 1992-09-02 Ciba-Geigy Ag Process for preparing an injectable liposome dispersion
CA2099588C (en) * 1990-12-03 2003-04-15 Larry J. Moore Prevention of synovial adhesions
ATE171071T1 (de) * 1991-12-31 1998-10-15 Zymogenetics Inc Verfahren und zusammensetzungen zur verminderung von blutverlust
PT100487B (pt) * 1992-05-14 1999-07-30 Univ Texas Formulacoes lipossomais de rifamicinas com elevada estabilidade e eficacia de incorporacao de antibiotico, e processo para a sua preparacao
ATE166573T1 (de) * 1993-03-24 1998-06-15 Ciba Geigy Ag Verfahren zur herstellung einer liposomendispersion im hochdruckbereich
DE69407292T2 (de) * 1993-06-30 1998-06-25 Genentech Inc Verfahren zur herstellung von liposomen
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
US6313106B1 (en) * 1995-06-07 2001-11-06 D-Pharm Ltd. Phospholipid derivatives of valproic acid and mixtures thereof
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
DE69734713T2 (de) * 1996-05-14 2006-07-06 Burzynski, Stanislaw R., Houston Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
US6723338B1 (en) * 1999-04-01 2004-04-20 Inex Pharmaceuticals Corporation Compositions and methods for treating lymphoma
GB9921958D0 (en) * 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
EP1337539A2 (en) * 2000-11-29 2003-08-27 Bracco International B.V. Linkable sialyl lewis x analogs
EP1909758A1 (en) * 2005-08-02 2008-04-16 I.D.M. Immuno-Designed Molecules Process for the preparation of liposomal formulations
JP4931527B2 (ja) * 2006-09-20 2012-05-16 富士フイルム株式会社 フッ素化ホスファチジルセリン化合物
EP2125031B1 (en) * 2006-12-19 2017-11-01 Marina Biotech, Inc. Lipids and lipid assemblies comprising transfection enhancer elements
US9758536B2 (en) 2011-12-07 2017-09-12 Omega Protein Corporation Phospholipid compositions enriched for palmitoleic, myristoleic or lauroleic acid, their preparation and their use in treating metabolic and cardiovascular disease
EP3470061A1 (en) 2012-11-20 2019-04-17 Spectrum Pharmaceuticals, Inc. Improved method for the preparation of a dosage of liposome encapsulated vincristine for therapeutic use
TWI678213B (zh) 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物
CN113995852B (zh) * 2021-11-08 2024-01-30 河北大学 Arg-脂质体微囊、微囊包封的鱼精蛋白-siRNA复合体及其制备方法和应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
USRE30748E (en) * 1976-10-12 1981-09-22 Phosphatidyl quaternary ammonium compounds
DE2647395C2 (de) * 1976-10-20 1984-03-29 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur Herstellung von Estern des Glycerophosphocholins
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4302459A (en) * 1980-03-19 1981-11-24 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
DE3209537A1 (de) * 1982-03-16 1983-09-22 Siemens AG, 1000 Berlin und 8000 München Elektrokleinmotor mit einer vorrichtung zum einstellen des axialspiels
DE3239817A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerinderivate zur synthese von phospholipiden
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
WO1986003938A1 (en) * 1985-01-11 1986-07-17 The Regents Of The University Of California Method for preserving liposomes
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators

Also Published As

Publication number Publication date
KR860003015A (ko) 1986-05-19
IL76700A (en) 1990-06-10
DK165220C (da) 1993-03-22
IL76700A0 (en) 1986-02-28
FI86371C (fi) 1992-08-25
DK471085A (da) 1986-04-17
ZA857888B (en) 1986-05-28
DK165220B (da) 1992-10-26
DD239117A5 (de) 1986-09-17
DE3580648D1 (de) 1991-01-03
JPH0816067B2 (ja) 1996-02-21
AU590221B2 (en) 1989-11-02
FI853982A0 (fi) 1985-10-14
ATE58474T1 (de) 1990-12-15
US4971802A (en) 1990-11-20
ES8700934A1 (es) 1986-11-16
CA1260393A (en) 1989-09-26
AU4871385A (en) 1986-04-24
HU198128B (en) 1989-08-28
NO171443B (no) 1992-12-07
JPH07238038A (ja) 1995-09-12
EP0178624B1 (de) 1990-11-22
HUT40332A (en) 1986-12-28
GR852492B (xx) 1986-02-11
NO171443C (no) 1993-03-17
EP0178624A2 (de) 1986-04-23
PH22978A (en) 1989-02-24
PT81298B (pt) 1988-02-17
JPH0618773B2 (ja) 1994-03-16
ES547889A0 (es) 1986-11-16
EP0178624A3 (en) 1987-05-27
DK471085D0 (da) 1985-10-15
NO854085L (no) 1986-04-17
IE58143B1 (en) 1993-07-14
PT81298A (en) 1985-11-01
FI86371B (fi) 1992-05-15
FI853982L (fi) 1986-04-17
KR890000908B1 (ko) 1989-04-13
JPS6197215A (ja) 1986-05-15
IE852527L (en) 1986-04-16

Similar Documents

Publication Publication Date Title
HK135793A (en) Liposomes from synthetic lipids
ZA851111B (en) Process for the manufacture of pharmaceutical compositions containing unilamellar liposomes
PT83872B (pt) Processo de preparacao de compostos de fosforo e de medicamentos contendo-os
ZA83224B (en) New-6-substituted-s-triazolo(3,4-a)phtalazine derivatives
EP0417581A3 (en) Process for the preparation of chemical substances containing thermoplastic polyurethanes
HUT45021A (en) Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
HUT55797A (en) Process for producing compounds inhibitting the activity of proteases having retroviral effect and pharmaceutical compositions comprising same
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
GR3025368T3 (en) Non active substance containing liposomes for the treatment of atherosclerosis
GB2045612B (en) Pharmaceutical compositions containing phosphatidic acids for the treatment of disorders of consciousness perception and movement
HUT52958A (en) Process for production of medical compositions assuring the constant release of the active substance
SE9002674D0 (sv) Foerfarande foer framstaellning av hoegrenad fosfatidylinositol
PT80961A (en) Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient
HUT37942A (en) Process for preparing 7-oxo-4-thia-1-azabicyclo /3.20/-hept-2-ene-derivatives of bactericidal effect and for preparing pharmaceutical compositions containing such compounds
ES2012792B3 (es) Procedimiento para la preparacion de ciclohixilhidroxiperoxido conteniendo mezcla de reaccion
HUT38322A (en) Herbicidal compositions comprising fluor-alkoxy-phenyl-sulfonyl-guanidines as active substance and process for the production of the active substances
PT87573A (pt) Process for the preparation of amidas pyrazine and of pharmaceutical compounds containing them
HUT43245A (en) Compounds containing as active substance hindering pollen formation derivatives of pirasole and process for production of the active substance
PT82656A (en) Process for the preparation of aducts of aluminium-amine phosphinate and of fungicidal compositions containing the same
CS5886A1 (en) Chamber for decomposition of torcreotic material
SU1086720A1 (ru) 1,1,1-трихлор-2-окси-4-(4-нитрофенил)бутанон-4 в качестве промежуточного продукта в синтезе 1,1,1-трихлор-4-(4-нитрофенил)бутен-2-она-4 и 1,1,1-трихлор-4-(4-нитрофенил)бутен-2-он-4 в качестве фунгицида
NO168101C (no) 6-fluor-5-methyl-1,2,3,4-tetrahydrokinaldin for anvendelse som utgangsmateriale ved fremstilling av terapeutisk aktive forbindelser

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20051013